Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Intercept Pharmaceuticals)"
Count: 27
Selected: 0
NCT IDTitle
NCT06121375Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
NCT05639543FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
NCT05321524Obeticholic Acid in Pediatric Subjects With Biliary Atresia
NCT05293938A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05292872Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05239468Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC
NCT04594694Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC
NCT03633227Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment
NCT03439254Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
NCT02633956Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
NCT02548351Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
NCT02308111Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
NCT02177136Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
NCT01933503Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
NCT01914562Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)
NCT01904539Hepatic Impairment Trial of Obeticholic Acid
NCT01865812Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
NCT01473524Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
NCT00570765Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
NCT00550862Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
NCT00501592Study of INT-747 in Patients With Diabetes and Presumed NAFLD
NCT05740631The Effect of Obeticholic Acid in Healthy Volunteers
NCT04265235EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study
NCT02654236Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling
NCT02039219Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
NCT02846896The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
NCT05479721LITMUS Imaging Study